COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 13, 2020
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
Severe Asthma: A 5-question POP Quiz
Severe asthma affects 5% to 10% of adults with asthma. Find out what you know about diagnosis and treatment options for these patients with 5 no-nonsense questions.
COVID-19 is Not my First Epidemic
The author was a young medical student when the first signs of the HIV epidemic appeared and it shaped his career. How will COVID-19 impact today's young clinicians?
DAPA-CKD Trial Findings Could Transform CKD Therapy
AHA: DAPD-CKD investigator Prof John McMurray talks to Patient Care about the “revolutionary” findings he will highlight at the AHA sessions on opening day.
George Bakris, MD, Lauds FIDELIO-CKD Findings, Discusses Finerenone
Finerenone, a non-steroidal, selective MRA, has distinct advantages over current treatments for diabetic kidney disease. Dr Bakris details these and the FIDELIO results.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 12, 2020
Global confirmed cases of COVID-19 have surpassed 52 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Black Patients Less Likely to Receive Treatment Intensification for BP Control
AHA 2020 Virtual Scientific Sessions: Nearly one-third of racial disparities in hypertension treatment may be linked to inequities in treatment intensification, study authors suggest.
Passive Smoke Exposure in Childhood May Cause Subclinical LV Dysfunction in Adults
AHA 2020 Virtual Scientific Sessions: Cumulative exposure, exposure intensity, and number of household smokers in childhood all impact adult heart function, study authors found.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 11, 2020
Global confirmed cases of COVID-19 have surpassed 51 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Survival Associated with Healthy Lifestyle Even with Multiple Meds on Board
AHA 2020 Virtual Scientific Sessions: Healthy lifestyle habits are inversely associated with-all cause mortality, study authors found.
Tezepelumab for Severe Asthma Meets Phase 3 Primary Endpoint
The novel monoclonal antibody could bring relief to millions of persons with severe, uncontrolled asthma, including those with a low eosinophil phenotype.
PREVIEW of AHA 2020 Scientific Sessions: Late-breaking Science, Days 4 and 5
Preview days 4 and 5 of the American Heart Association 2020 live late-breaking science sessions. Decide what you need to watch and when.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 10, 2020
US confirmed cases of COVID-19 have surpassed 10 million; global cases have reached 50 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
AHA 2020 Scientific Sessions Preview: Late-breaking Science, Days 1, 2 and 3
What to watch during the AHA 2020 late-breaking science sessions? We break down the first 3 days of clinical trial presentations for you, here.
Higher Green Tea and Coffee Intake May Reduce Mortality Risk in Patients with T2D
A new study of Japanese adults with type 2 diabetes found dual consumption of green tea and coffee reduced mortality risk by >60%.
Pfizer COVID-19 Vaccine Candidate Achieves 90% Efficacy
Pfizer/BioNTech announced more than 90% efficacy for their vaccine against SARS-CoV-2 infection in the first interim analysis of phase 3 study.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 9, 2020
Global confirmed cases of COVID-19 have surpassed 50 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Ticagrelor Wins Label Expansion to Reduce Risk of Recurrent Stroke, TIA
FDA approval is based on results of the phase III THALES trial, in which DAPT with ticagrelor and aspirin for 30 days reduced the rate of stroke and death by 17% vs aspirin alone.
COPD Self-management App Reduces Exacerbations, Readmissions vs Usual Care
Use of the myCOPD app after hospitalization for acute COPD exacerbation reduced subsequent exacerbations by nearly 50%, according to study authors.
Telemedicine Gains More Ground During COVID-19
A recent survey conducted by Doximity found that US physician and patient adoption of telemedicine is quickly rising amid the COVID-19 pandemic.
